权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Posttranscriptional Gene Regulation in Asthma

哮喘的转录后基因调控

基本信息

批准号：
7847589
负责人：
ULUS ATASOY
金额：
$ 17.87万
依托单位：
UNIVERSITY OF MISSOURI-COLUMBIA
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-05-22 至 2012-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7847589
关键词：
3&apos Untranslated Regions Affect Allergens Allergic inflammation Animal Model Animals Area Asthma Binding Biological Biological Assay Boxing CD4 Positive T Lymphocytes Cell Nucleus Cloning Complex Cytokine Gene Cytoplasm Data Development Disabled Persons Disease ERG gene Elements Employee Strikes Extrinsic asthma Functional disorder Gene Expression Gene Expression Regulation Gene Targeting Genes Genetic Goals Human Hypersensitivity IL13 gene Immunoprecipitation Indium Inflammation Inflammatory Inflammatory Response Interferons Interleukin-13 Interleukin-4 Knock-out Lead Lentivirus Vector Messenger RNA Methods Modality Modeling Mus Operon Outcome Ovalbumin Ovum Pathogenesis Patients Phenotype Physicians Play Prevalence Production Proteins Public Health Publishing RNA-Binding Proteins Regulation Reporting Research Research Personnel Role Scientist Severities T-Cell Activation Testing Therapeutic Time Tissues Translations Untranslated Regions Up-Regulation Work allergic airway inflammation base cDNA Arrays chemokine cytokine design experience handicapping condition in vivo innovation loss of function mRNA Stability novel novel strategies public health relevance response

项目摘要

DESCRIPTION (provided by applicant): Asthma has been increasing in prevalence and severity for unknown reasons. Though our understanding of the pathophysiology remains poor, it is widely accepted that asthma is an inflammatory disease and CD4+ T cells elaborating Th2 cytokines have been identified as major culprits in its development. Many of these genes are posttranscriptionally regulated but their regulation is not well understood. Current approaches have emphasized the use of microarrays to define "asthma signature genes". Though these approaches are helpful, they are also incomplete and may miss important target genes since there is a poor correlation between steady-state mRNA levels and protein production. We have developed a new paradigm, the posttranscriptional operon hypothesis, which states that RNA binding proteins are coordinately regulating the expression of biologically related molecules, such as those involved in T cell activation. Our central hypothesis is that the RNA binding protein, HuR, is coordinately regulating IL-4 and IL-13 cytokine genes during allergen driven asthma. The RNA binding protein, HuR, binds to the AU-rich elements (ARE) in the 3' untranslated regions (UTR) of mRNAs and modulates their stability and translation. The ARE motif is found in 8% of human genes and plays a critical role in posttranscriptional gene expression. In particular, two major Th2 cytokines, IL- 4 and IL-13, believed to play critical roles in allergen driven asthma, are regulated by HuR at the level of mRNA stability and translation. We have developed novel methods to identify en masse cellular in vivo HuR mRNA targets. Using these approaches, we have identified IL-4 and IL-13 as HuR targets. We will test this hypothesis with the following two specific aims: 1: Examine the effects of HuR modulation in CD4+ T cells upon IL-4 and IL-13 expression. 2: Assess the role of HuR in CD4+ T cells in allergen driven models of asthma in mice. Our approach will provide a fuller understanding of the regulation of proinflammatory cytokine genes involved in allergen driven asthma. Better understanding of proinflammatory gene regulation at posttranscriptional level may potentially lead to targeted therapies to treat asthma. Public Health Relevance: The rise of allergies and asthma around the world continues to perplex physicians and scientists. The reasons for this increase are unknown. Different responses to therapies for asthma are most likely due to differences in genetic backgrounds of patients. A better understanding of asthma pathophysiology at the posttranscriptional gene regulation level would greatly aid in our understanding of disease pathogenesis and treatment and have a direct impact on public health.

描述（由申请人提供）：由于未知原因，哮喘的患病率和严重程度一直在增加。尽管我们对哮喘的病理生理机制的理解仍然很差，但人们普遍认为哮喘是一种炎症性疾病，并且CD 4 + T细胞分泌Th 2细胞因子已被确定为其发展的主要罪魁祸首。这些基因中有许多是转录后调控的，但它们的调控还不清楚。目前的方法强调使用微阵列来定义“哮喘特征基因”。虽然这些方法是有帮助的，但它们也是不完整的，可能会错过重要的靶基因，因为稳态mRNA水平和蛋白质产生之间的相关性很差。我们已经开发了一种新的范式，转录后操纵子假说，它指出，RNA结合蛋白协调调节生物相关分子的表达，如参与T细胞活化。我们的中心假设是RNA结合蛋白HuR在过敏原驱动的哮喘中协同调节IL-4和IL-13细胞因子基因。RNA结合蛋白HuR与mRNA的3'非翻译区（UTR）中的富含AU的元件（ARE）结合并调节其稳定性和翻译。ARE基序存在于8%的人类基因中，在转录后基因表达中起着关键作用。特别是，两种主要的Th 2细胞因子，IL- 4和IL-13，被认为在过敏原驱动的哮喘中起关键作用，在mRNA稳定性和翻译水平上受到HuR的调节。我们已经开发了新的方法来鉴定细胞内体内HuR mRNA靶点。使用这些方法，我们已经将IL-4和IL-13鉴定为HuR靶标。我们将用以下两个具体目标来检验这一假设：1：检查CD 4 + T细胞中HuR调节对IL-4和IL-13表达的影响。2：评估HuR在小鼠过敏原驱动的哮喘模型中在CD 4 + T细胞中的作用。我们的方法将提供一个更全面的了解参与过敏原驱动哮喘的促炎细胞因子基因的调节。更好地了解促炎基因在转录后水平的调控可能会导致潜在的靶向治疗哮喘。公共卫生相关性：世界各地过敏和哮喘的增加继续困扰着医生和科学家。这种增长的原因尚不清楚。对哮喘治疗的不同反应很可能是由于患者遗传背景的差异。在转录后基因调控水平上更好地理解哮喘的病理生理学将极大地帮助我们理解疾病的发病机制和治疗，并对公众健康产生直接影响。